NasdaqGS:ISRGMedical Equipment
Assessing Intuitive Surgical (ISRG) Valuation After 2026 da Vinci Growth Outlook And AI Recurring Revenue Update
Intuitive Surgical (ISRG) has updated investors on its 2026 outlook, guiding for 13% to 15% global da Vinci procedure growth, supported by U.S. general surgery, broader international adoption, and the commercial rollout of the da Vinci 5 system.
See our latest analysis for Intuitive Surgical.
That 13% to 15% procedure growth outlook comes after a choppy stretch for the share price, with a 30 day share price return of 11.14% and a year to date share price decline of 13.55%, while the 3 year...